Acquiring Company
Sun Pharmaceutical Industries Ltd
Acquired Company
Organon
Jersey CityBiotechnologyHealth CareBiotechnologyHealth CareMedicalDescription
Sun Pharmaceutical Industries Ltd is nearing a deal to acquire US-based Organon & Co. in a transaction valued at around $12 billion. This would mark Sun Pharma's largest acquisition to date, raising concerns among investors about potential impacts on the company's balance sheet. The scale of the deal is prompting cautious sentiment in the market as participants evaluate risks and rewards.
Quick answer
Sun Pharmaceutical Industries Ltd is acquiring Organon for $12 billion, announced April 10, 2026.
- How much did Sun Pharmaceutical Industries Ltd pay for Organon?
- The reported deal value is $12 billion.
- What does Sun Pharmaceutical Industries Ltd do?
- Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India.
- Where are Sun Pharmaceutical Industries Ltd and Organon based?
- Organon is based in Jersey City, New Jersey, United States.
- Who are the decision-makers at Sun Pharmaceutical Industries Ltd?
- Fundz holds 3 contacts at Sun Pharmaceutical Industries Ltd. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Medtronic to acquire SPR Therapeutics for chronic pain care (May 20, 2026)
- Abbott to acquire Surmodics for $1.4 billion, $1.4B (May 19, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
- Panthera Biopartners acquires OEC in Hungary (April 26, 2026)
- WCG to acquire The Contract Network for enhanced AI (April 21, 2026)
- Lupin completes acquisition of VISUfarma (April 2, 2026)
Who to call at Sun Pharmaceutical Industries Ltd, and when
When Sun Pharmaceutical Industries Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Sun Pharmaceutical Industries Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sun Pharmaceutical Industries Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sun Pharmaceutical Industries Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sun Pharmaceutical Industries Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Organon?
Organon was acquired by Sun Pharmaceutical Industries Ltd. The deal was reported on April 10, 2026. Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. Sun Pharmaceutical Industries Ltd is privately held and operates in Biotechnology.
When did Sun Pharmaceutical Industries Ltd acquire Organon?
Sun Pharmaceutical Industries Ltd's acquisition of Organon was reported on April 10, 2026. Sun Pharmaceutical Industries Ltd is nearing a deal to acquire US-based Organon & Co. in a transaction valued at around $12 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Organon do?
Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. It is publicly traded (OGN), operating in Biotechnology, and is based in Jersey City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.